Selenium and selenoproteins in health

F Zhang, X Li, Y Wei - Biomolecules, 2023 - mdpi.com
Selenium is a trace mineral that is essential for health. After being obtained from food and
taken up by the liver, selenium performs various physiological functions in the body in the …

Ferroptosis: mechanisms and implications for cancer development and therapy response

AF Dos Santos, G Fazeli, TNX da Silva, JPF Angeli - Trends in cell biology, 2023 - cell.com
As cancer cells develop resistance to apoptosis, non-apoptotic cell death modalities, such
as ferroptosis, have emerged as promising strategies to combat therapy-resistant cancers …

Selenoprotein P–Selenium transport protein, enzyme and biomarker of selenium status

L Schomburg - Free Radical Biology and Medicine, 2022 - Elsevier
The habitual intake of selenium (Se) varies strongly around the world, and many people are
at risk of inadequate supply and health risks from Se deficiency. Within the human organism …

7-Dehydrocholesterol is an endogenous suppressor of ferroptosis

FP Freitas, H Alborzinia, AF Dos Santos… - Nature, 2024 - nature.com
Ferroptosis is a form of cell death that has received considerable attention not only as a
means to eradicate defined tumour entities but also because it provides unforeseen insights …

The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions

G Lei, L Zhuang, B Gan - Cancer cell, 2024 - cell.com
In cancer treatment, the recurrent challenge of inducing apoptosis through conventional
therapeutic modalities, often thwarted by therapy resistance, emphasizes the critical need to …

[HTML][HTML] The selenophosphate synthetase family: A review

B Manta, NE Makarova, M Mariotti - Free Radical Biology and Medicine, 2022 - Elsevier
Selenophosphate synthetases use selenium and ATP to synthesize selenophosphate. This
is required for biological utilization of selenium, most notably for the synthesis of the non …

Therapeutic benefits of selenium in hematological malignancies

MA Ehudin, U Golla, D Trivedi, SD Potlakayala… - International journal of …, 2022 - mdpi.com
Supplementing chemotherapy and radiotherapy with selenium has been shown to have
benefits against various cancers. This approach has also been shown to alleviate the side …

Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells

F Qian, SK Nettleford, J Zhou, BE Arner, MA Hall… - Cell reports, 2023 - cell.com
Relapse of acute myeloid leukemia (AML) remains a significant concern due to persistent
leukemia-initiating stem cells (LICs) that are typically not targeted by most existing therapies …

Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation

V Dembitz, H Lawson, R Burt, S Natani, C Philippe… - Leukemia, 2024 - nature.com
Identification of specific and therapeutically actionable vulnerabilities, ideally present across
multiple mutational backgrounds, is needed to improve acute myeloid leukemia (AML) …

The logic of native enhancer-promoter compatibility and cell-type-specific gene expression variation

T Narita, Y Higashijima, S Kilic, E Maskey, K Neumann… - bioRxiv, 2022 - biorxiv.org
Cis-regulatory enhancers are essential for differential expression of developmental and
housekeeping genes. However, the specificity of native mammalian enhancers and how it …